26U vs NVS: Side-by-Side Comparison
Compare 26U (26U) and Novartis AG (NVS) side by side: market cap EUR 127.86M vs USD 305.10B. Financials, growth and model signals on Bullrun.
| Metric | 26U | NVS |
|---|---|---|
| Company | 26U | Novartis AG |
| Country / Exchange | Switzerland · F | Switzerland · NYSE |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers-General |
| Market cap | EUR 127.86M | USD 305.10B |
| P/E ratio | — | 22.8 |
| Dividend yield | — | 2.98% |
| Valuation model | — | 8.9% undervalued |
| Revenue (latest FY) | EUR 10.80M | — |
| Revenue growth YoY | +56.6% | — |
| Net income | EUR -1.42M | — |
| Gross margin | 26.3% | — |
| Diluted EPS | -0.28 | — |